Prudentia Sciences, a technology company, is dedicated to accelerating drug pipelines and maximizing return on investment, envisioning a future where healthcare innovations reach their full potential. Prudentia's platform enables comprehensive due diligence and valuation of drug assets.
|
Date |
Amount |
Type |
Investors |
Valuation |
|---|---|---|---|---|
| 01/09/25 | $7,000,000 | Seed |
GV Iaso Ventures Virtue | undisclosed |
